Evidence map›Paper›PMID 27699583›Full record

ArticleThe journal of physiological sciences : JPS2017

Prostaglandins mediate zymosan-induced sickness behavior in mice.

Juliana B M Lima, Clarice C Veloso, Fabiana C Vilela, Alexandre Giusti-Paiva

Open access · goldAbstract read
In one paragraph

Article in The journal of physiological sciences : JPS, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 17 citations in OpenAlex.

  1. Proximate and ultimate causes of pregnancy sickness.Evolution, medicine, and public health · 2025
    Review
  2. Article
  3. Interleukin-1β and cathepsin D modulate formation of the terminal complement complex in cultured human disc tissue.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2021
    Article
  4. Article
  5. (E)-2-Cyano-3-(1International journal of molecular sciences · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Juliana B M LimaDepartment of Physiology, Ribeirão Preto School of Medicine, University of São Paulo, Ribeirão Preto, Brazil.
Clarice C VelosoLaboratory of Translational Physiology, Department of Physiological Sciences, Institute of Biomedical Sciences, Federal University of Alfenas-MG, Av. Jovino Fernandes Sales, 2600 Prédio E, Sala 300, 37130-000, Alfenas, MG, Brazil.
Fabiana C VilelaLaboratory of Translational Physiology, Department of Physiological Sciences, Institute of Biomedical Sciences, Federal University of Alfenas-MG, Av. Jovino Fernandes Sales, 2600 Prédio E, Sala 300, 37130-000, Alfenas, MG, Brazil.
Alexandre Giusti-PaivaLaboratory of Translational Physiology, Department of Physiological Sciences, Institute of Biomedical Sciences, Federal University of Alfenas-MG, Av. Jovino Fernandes Sales, 2600 Prédio E, Sala 300, 37130-000, Alfenas, MG, Brazil. agiustipaiva@gmail.com.ORCID http://orcid.org/0000-0001-5059-9988
Universidade Federal de Alfenas · BRUniversidade de São Paulo · BR

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 300977/2013-1Fundação de Apoio a Pesquisa do Estado de Minas Gerais (FAPEMIG) APQ-00041-15
6 · The paper itself

Abstract

Previous studies have demonstrated that zymosan, a cell wall component of the yeast Saccharomyces cerevisiae, induces inflammation in experimental models. However, few studies have evaluated the potential of zymosan to induce sickness behavior, a central motivational state that allows an organism to cope with infection. To determine whether zymosan administration results in sickness behavior, mice were submitted to the forced swim (FST) and open field (OFT) tests 2, 6, and 24 h after treatment with zymosan (1, 10, or 100 mg/kg). Additionally, to evaluate the possible relationship between zymosan-induced sickness behavior and prostaglandin synthesis, mice were pretreated with the cyclooxygenase inhibitors indomethacin (10 mg/kg) and nimesulide (5 mg/kg) and the glucocorticoid drug dexamethasone (1 mg/kg). Zymosan induced time-dependent decreases in locomotor activity in the OFT, and an increase in immobility in the FST, and increased plasma levels of corticosterone at 2 h. Pretreatment with indomethacin, nimesulide, or dexamethasone blocked zymosan-induced behavioral changes in both the FST and OFT at 2 h post administration. These findings confirm previous observations that zymosan induces sickness behavior. Furthermore, our results provide new evidence that prostaglandin synthesis is necessary for this effect, as anti-inflammatory drugs that inhibit prostaglandin synthesis attenuated zymosan-induced behavioral changes.

Indexed as

AnimalsBehavior, AnimalDexamethasoneDose-Response Relationship, DrugGlucocorticoidsIllness BehaviorIndomethacinMaleMiceProstaglandin AntagonistsProstaglandinsSulfonamidesZymosanDexamethasoneGlucocorticoidsIndomethacinnimesulideProstaglandin AntagonistsProstaglandinsSulfonamidesZymosanCyclooxygenaseFungal infectionProstaglandinSaccharomyces cerevisiaeSickness behaviorZymosan

Identifiers

PMID27699583
PMCPMC10717961
OpenAlexW2528958207

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.